Short-and Long-Term Expression of Vegf: A Temporal Regulation of a Key Factor in Diabetic Retinopathy.
ELAV/HuR
VEGF
akita mouse
diabetes
hyperglycemia
retinopathy
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2021
2021
Historique:
received:
10
05
2021
accepted:
06
08
2021
entrez:
7
9
2021
pubmed:
8
9
2021
medline:
8
9
2021
Statut:
epublish
Résumé
To investigate the role of vascular endothelial growth factor (VEGF) at different phases of diabetic retinopathy (DR), we assessed the retinal protein expression of VEGF-A
Identifiants
pubmed: 34489701
doi: 10.3389/fphar.2021.707909
pii: 707909
pmc: PMC8418071
doi:
Types de publication
Journal Article
Langues
eng
Pagination
707909Informations de copyright
Copyright © 2021 Bucolo, Barbieri, Viganò, Marchesi, Bandello, Drago, Govoni, Zerbini and Pascale.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cell Adh Migr. 2012 Nov-Dec;6(6):561-8
pubmed: 23076130
Curr Diab Rep. 2015 Feb;15(2):573
pubmed: 25620405
Diabetologia. 2005 Nov;48(11):2422-7
pubmed: 16193288
Drugs Context. 2018 Aug 13;7:212532
pubmed: 30181760
Am J Pathol. 2010 Mar;176(3):1517-24
pubmed: 20110406
Invest Ophthalmol Vis Sci. 2013 Jan 17;54(1):574-84
pubmed: 23221078
Surv Ophthalmol. 2002 Dec;47 Suppl 2:S263-9
pubmed: 12507628
Pharmacol Res. 2008 Jan;57(1):60-6
pubmed: 18206386
Diabetes Care. 2016 Sep;39(9):1643-9
pubmed: 27555623
Nat Rev Drug Discov. 2016 Jun;15(6):385-403
pubmed: 26775688
Diabetologia. 2018 Jan;61(1):29-38
pubmed: 28942458
Biochem Pharmacol. 2020 May;175:113908
pubmed: 32171729
Invest Ophthalmol Vis Sci. 2010 Oct;51(10):5226-33
pubmed: 20445124
Best Pract Res Clin Endocrinol Metab. 2007 Dec;21(4):573-86
pubmed: 18054736
Pharmacol Res. 2016 Jan;103:253-69
pubmed: 26678602
Clin Exp Ophthalmol. 2013 Aug;41(6):582-92
pubmed: 23433122
Pharmacol Res. 2016 Sep;111:713-720
pubmed: 27475885
Drug Discov Today. 2019 Aug;24(8):1499-1509
pubmed: 30954684
Biochem Soc Trans. 2009 Dec;37(Pt 6):1207-13
pubmed: 19909248
Pharmacol Res. 2007 Jun;55(6):461-6
pubmed: 17582783
Cell Mol Life Sci. 2012 Feb;69(4):501-17
pubmed: 21909784
N Engl J Med. 2012 Mar 29;366(13):1227-39
pubmed: 22455417
Mol Vis. 2012;18:2153-64
pubmed: 22879735
Rev Med Liege. 2020 May;75(5-6):432-439
pubmed: 32496693
Oncotarget. 2017 Aug 3;8(47):83038-83051
pubmed: 29137322
PLoS One. 2012;7(5):e35231
pubmed: 22567098
PLoS One. 2020 Nov 30;15(11):e0242627
pubmed: 33253266
Front Pharmacol. 2015 Oct 29;6:248
pubmed: 26578958
Sci Rep. 2017 Dec;7(1):58
pubmed: 28246395
Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H738-49
pubmed: 27473938
Biochem Pharmacol. 2010 Oct 15;80(8):1230-7
pubmed: 20599775
Curr Pharm Des. 2010;16(6):660-71
pubmed: 20388076
Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2210-8
pubmed: 15914643
Biochem Pharmacol. 2019 Jun;164:321-325
pubmed: 31039332
Curr Diab Rep. 2017 Aug 24;17(10):93
pubmed: 28836097
Jpn J Ophthalmol. 2007 Nov-Dec;51(6):424-30
pubmed: 18158592
J Diabetes Res. 2016;2016:9051426
pubmed: 27595114